About

Dr. Li’s research focuses on the development and validation of novel radiolabeling methods and multimodality molecular imaging probes for visualization and quantification of various molecular targets related to neuro, cardiac, diabetes, and cancer research. Radiochemistry is the central, ongoing focus of Dr. Li’s research. He has obtained comprehensive experience with various radioisotopes, including ¹¹C, ¹⁸F and ⁶⁴Cu and has a broad background on radiochemistry, organic chemistry, multimodality molecular imaging, nano-medicine, and translational research. He additionally has extensive experience on process optimization in order to produce clinically translatable radiopharmaceuticals, as well as over 10 years of experience on producing high quality radiotracers for human research application under cGMP conditions.